Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05109923
What this trial is testing

Onnit Labs New Mood Supplementation in Healthy College Students

Who this might be right for
Mental Health Wellness 1
University of Idaho 56
Early research (Phase 1)Study completedNCT02973802
What this trial is testing

ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy

Who this might be right for
Graves Disease
Apitope International NV 12
Not applicableStudy completedNCT06031103
What this trial is testing

Clinical Efficacy of Mini-PCNLversus RIRS for the Management of Upper Urinary Tract Calculus (1-2.5 cm)

Who this might be right for
Stone, Kidney
Ain Shams University 60
Early research (Phase 1)Looking for participantsNCT05856981
What this trial is testing

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorRefractory Cancer+4 more
Sairopa B.V. 130
Large-scale testing (Phase 3)Active Not RecruitingNCT01805271
What this trial is testing

Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy

Who this might be right for
Primary Non-metastatic Breast CancerWho Remain Disease-free
UNICANCER 1,278
Early research (Phase 1)Active Not RecruitingNCT01366144
What this trial is testing

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryEndometrial Carcinoma+11 more
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Looking for participantsNCT07317544
What this trial is testing

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia (AGA)Healthy Volunteers - Male and Female
Absci Pty Ltd. 227
Testing effectiveness (Phase 2)Ended earlyNCT03284957
What this trial is testing

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 136
Post-approval studies (Phase 4)Active Not RecruitingNCT05096195
What this trial is testing

PRevEnting FracturEs in REnal Disease - 1

Who this might be right for
Kidney DiseasesDialysis; ComplicationsFragility Fracture+1 more
Western University, Canada 60
Early research (Phase 1)Active Not RecruitingNCT07523711
What this trial is testing

Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or Obesity

Who this might be right for
OverweightObesity
Amgen 49
Early research (Phase 1)Study completedNCT03960645
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety, and Efficacy of B/F/TAF in Human Immunodeficiency Virus (HIV)-1 Infected, Virologically Suppressed, Pregnant Women in Their Second and Third Trimesters

Who this might be right for
HIV-1-infection
Gilead Sciences 62
Early research (Phase 1)Looking for participantsNCT07593092
What this trial is testing

Phase 1, Safety and Tolerability Study of XmAb541 and XmAb808 in Advanced Solid Tumors

Who this might be right for
Ovarian Cancer
Xencor, Inc. 90
Post-approval studies (Phase 4)Study completedNCT00479037
What this trial is testing

Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)

Who this might be right for
Osteoporosis
Nycomed 82
Not applicableStudy completedNCT04769167
What this trial is testing

Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes

Who this might be right for
Congenital Heart DiseaseViremiaVirus Diseases+12 more
Washington University School of Medicine 114
Not applicableLooking for participantsNCT05258292
What this trial is testing

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Who this might be right for
Type1diabetes
Institut de Recherches Cliniques de Montreal 86
Early research (Phase 1)Study completedNCT00473954
What this trial is testing

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
EGEN, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT04939701
What this trial is testing

Study of ASP0739 Alone and With Pembrolizumab in Advanced Solid Tumors With NY-ESO-1 Expression Participants

Who this might be right for
Ovarian CancerNSCLCESCC+1 more
Astellas Pharma Global Development, Inc. 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT00788671
What this trial is testing

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 69
Early research (Phase 1)Not Yet RecruitingNCT07777133
What this trial is testing

Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants

Who this might be right for
Healthy Female Participants
Bristol-Myers Squibb 6
Not applicableUnknownNCT00855998
What this trial is testing

Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer

Who this might be right for
Breast CancerOvarian Cancer
Hadassah Medical Organization 300
Next Page